Description

Arikayce is an antibiotic medication used to treat lung infections caused by Mycobacterium avium complex (MAC) in patients with cystic fibrosis or other underlying lung conditions. It is administered via inhalation and is typically prescribed when other treatments have failed.

Interpreter Notes

Interpreters should be aware that Arikayce may be referred to by its generic name, amikacin liposome inhalation suspension, in some contexts. It is important to maintain a formal register and avoid colloquial terms. Ensure clarity when discussing the specific use of this medication for MAC infections.

Example Sentences

EN: The doctor prescribed Arikayce to help manage the patient's lung infection.

ES: El médico recetó Arikayce para ayudar a controlar la infección pulmonar del paciente.

Common Interpreter Mistakes

Confusing Arikayce with other antibiotics; mispronouncing 'amikacin' as 'aminoglucósido'; mixing up indications for cystic fibrosis and other lung conditions.